H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 322,570. Kentucky Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lexington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lexington storefront.
Knee Joint Biologic Injections in Lexington, KY for clinics & physicians. Biologic injections for knee pai… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Lexington is J15 (CGS Administrators) and that adult diabetes here is not published at city grain — use national 12%, it is selling units, not a program. That is the knee joint biologic injections conversation we actually have.
National Knee Joint Biologic Injections notes (how the product actually works)Three grains, kept separate on purpose. City: Census 322,570 and CDC PLACES crude rates. State: Kentucky Cabinet for Health & Family Services, Diabetes Belt counties present. Federal: 21 CFR 1271 and CGS Administrators LCDs. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Lexington trial. Local outcomes stay with the treating physician. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Use that rate for inventory math, not for ads.
CDC PLACES has no incorporated-place row we could match for Lexington. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J15 reviewers and surveyors expect — not a brochure.
Kentucky is in CMS MAC J15, administered by CGS Administrators. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Bring specialty, monthly joint / regenerative volume, and whether you bill J15 FFS, Advantage, workers’ comp, or cash-pay. PLACES has no city row here; bring your own panel mix. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Lexington, KY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lexington is J15 geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Kentucky Part B wound biologics follow this contractor (siblings: OH). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 250k–500k, not a count of orthopedic groups.
No Lexington storefront. Joe Bradley is an active practice owner. knee joint biologic injections stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.